PPD Earns Award for Innovation in Training and Development

Learning culture empowers employees, improves performance
for biopharma clients

16 May 2013


WILMINGTON, N.C., (May 16, 2013) – Pharmaceutical Product Development, LLC (PPD) today announced that Skillsoft has named PPD a winner of the 2013 Skillsoft Perspectives Innovation Award for Empowering Learning Cultures in the Enterprise.

Judged by an independent panel of industry experts, the Skillsoft award honors the organization that best demonstrates the ability to make learning part of the fabric of its operations, empowering employees to take charge of their professional growth and development, promoting knowledge sharing and measuring results.

“PPD is focused on continually improving performance to create efficiencies in cost, time and quality for our clients’ research programs,” said Ed Murray, senior vice president, human resources for PPD. “We are at the forefront of e-learning, virtual learning and other leading development platforms and curricula that drive employee engagement and performance improvement by enabling employees to advance their skills and expertise. With nearly 30 years of experience in the biopharmaceutical services industry, PPD understands that high-performing employees help drive success for our clients.”

To meet and surpass biopharmaceutical clients’ needs in developing new, life-changing therapies, PPD has implemented multiple learning and development programs. At the foundation of PPD’s employee learning focus is a strategic collaboration between the human resources team and the technology, innovation and performance (TIP) group, which blends novel concepts of learning and development with an array of resources used globally to enhance employees’ expertise.

PPD accepted the award at the 2013 Global Skillsoft Perspectives user conference in Orlando, Fla. The recognition follows PPD’s honorable mention as Program of the Year by Skillsoft in 2012.

Additional recent awards for PPD’s excellence in technology and employee learning include: ranking on the 2012 and 2013 Training Top 125 lists of businesses excelling in employee development; being ranked on the InformationWeek 500 list of most innovative users of business technology for three consecutive years; and earning a 2012 Scrip Award for best technological development in clinical trials for PPD® 3D, a virtual collaboration technology designed to improve the cost-effectiveness, speed and quality of clinical trial training.

As a pioneer in the field of learning with a long history of innovation, Skillsoft created its awards program to recognize innovative ideas, powerful programs and inspiring leaders who help transform the corporate learning landscape by leveraging the company’s products and services.

Lee Kennedy
+1 919 456 5350

Luke Heagle
+1 910 558 7585

About PPD
PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 12,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.

Except for historical information, all of the statements, expectations and assumptions, including statements, expectations and assumptions about PPD’s Skillsoft Perspectives Innovation Award, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based and could cause actual results to differ materially from the forward-looking statements. Other important factors that could cause future results to differ materially include the following: the ability to attract, integrate and retain key personnel; competition in the outsourcing industry; compliance with drug development regulations; changes in the regulation of the drug development process; overall global economic conditions; economic conditions, research and development spending, and outsourcing trends in the pharmaceutical, biotechnology and government-sponsored research sectors; consolidation in the pharmaceutical and biotechnology industries; PPD’s ability to win new business; loss, delay or modification of large contracts; higher-than-expected cancellation rates; the rate of conversion of backlog into revenue; actual operating performance; risks associated with and dependence on strategic relationships; risks associated with acquisitions and investments; the ability to control SG&A spending; and rapid technological advances that make our services less competitive. PPD assumes no obligation and expressly disclaims any duty to update these forward-looking statements in the future, except as required by applicable law. These forward-looking statements should not be relied upon as representing PPD’s estimates or views as of any date subsequent to the date hereof.

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
Tel: +1 919 456 4425

Holly Devine Manager, Corporate Communications
Tel: +1 919 456 6389

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.